Skip to content
lifestyle.rogueimc.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
enVVeno Medical Corporation
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
July 31, 2026
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
June 2, 2026
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor “What This Means” Segment
May 12, 2026
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
May 7, 2026
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
April 29, 2026
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
March 27, 2026
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 10, 2026